ACE and type 2 diabetes mellitus: From an interventional perspective, Elajami et al. (10) showed, that EPA and DHA supplementation was able to attenuate the progression of established albuminuria in patients with type 2 diabetes mellitus and coronary artery disease, most of whom were already under treatment with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.